EP-ZQ110 IBM-i masin — Jomar IBM135 asendus

PP and HDPE tablet, syrup and oral liquid bottles at 30–1000 ml. 14 cavities at 100 ml format within Korean MFDS GMP cleanrooms where EP-ZQ110's 2.2 m height qualifies and IBM135's 3.41 m cannot. At 35 g per preform × 14 cavities = 490 g, within EP-ZQ110's 540 g limit with 50 g headroom for heavier-wall pharmaceutical grades.

24 cavities at 10 ml PCTG eye serum droppers, 22 cavities at 30 ml PCTG facial serum vials with S136 SPI A1 glass-look tooling. EP-ZQ110's 1,100 mm wide platen enables this cavity count directly — IBM135-class 559 mm platen constrains the same format to approximately 14 mandrel positions regardless of shot weight capacity.

PP and PCTG shampoo, body wash and fragrance bottles at 100–1000 ml in 6–14 cavity configurations. At 540 g shot, EP-ZQ110 supports 8 cavities at 500 ml PP shampoo (55 g per bottle, 440 g total) and 6 cavities at 1000 ml PP conditioner (80 g per bottle, 480 g within 540 g limit).

PP and HDPE supplement capsule and vitamin containers at 250–5000 ml. Volume range to 5000 ml on EP-ZQ110 covers the complete Korean dietary supplement primary packaging range from travel-size to large-format club-pack containers.

Q1: Can Jomar IBM135 mould tooling be used on the EP-ZQ110?

Not without major adaptation. IBM135-class platen dimensions (559 × 1,118 mm) have a fundamentally different geometry from EP-ZQ110 (1,100 × 460 mm) — tall and narrow versus wide and low-profile. The platen orientation, mandrel pitch, mould thickness and bolt-hole configuration are incompatible for direct transfer. In most cases IBM135 tooling cannot be adapted to EP-ZQ110 and new mould tooling must be designed to the EP-ZQ110 platen specification. Send IBM135 mould base drawings for a Korea Ever-Power assessment — we advise within 5 working days at no cost.

Q2: Jomar IBM135 has 1,210 kN clamping vs EP-ZQ110's 1,100 kN — is IBM135 significantly better?

The IBM135's 110 kN additional clamping (10% above EP-ZQ110) is modest in practice. At 14 cavities for 100 ml pharmaceutical production: EP-ZQ110 at 1,100 kN distributes 78.6 kN per injection cavity; IBM135 at 1,210 kN distributes 86.4 kN per cavity — a 7.8 kN per cavity difference that is within standard process variation for pharmaceutical PP and HDPE bottle IBM production where typical cavity clamping requirements are 50–80 kN per cavity. The 10% clamping advantage of IBM135 does not translate to a meaningful production output difference for the application range this tonnage class addresses. The decisive advantages of EP-ZQ110 — 35% shorter, 25% narrower, platen nearly double the width, 24 cavities at 10 ml — substantially outweigh the marginal clamping difference.

Q3: How does EP-ZQ110's 1,100mm wide platen enable 24 cavities at 10ml when IBM135 at 559mm cannot?

At 10 ml format with 38 mm mandrel centre-to-centre pitch: EP-ZQ110's 1,100 mm effective platen accommodates 24 mandrel positions in a single row (24 × 38 mm = 912 mm, within 1,100 mm limit with 188 mm to spare for tooling structure). IBM135's 559 mm platen accommodates approximately 14 mandrel positions in the same format (14 × 38 mm = 532 mm, within 559 mm limit). IBM135's taller platen (1,118 mm) could theoretically accommodate a dual-row mandrel layout, but dual-row IBM mandrel tooling is not standard for pharmaceutical and cosmetic IBM production — it significantly increases tooling complexity, cost and maintenance requirements. EP-ZQ110's 1,100 mm wide single-row platen is the practical solution for high-cavity-count IBM at the 110-tonne class.

Q4: Can EP-ZQ110 at 2.2m height install in a Korean pharmaceutical GMP cleanroom where IBM135 at 3.41m cannot?

Yes. EP-ZQ110 at 2.2 m fits Korean pharmaceutical GMP cleanrooms with 2.7 m ceiling clearance (0.5 m overhead — minimum for barrel heater access). In 3.0 m ceiling cleanrooms, EP-ZQ110 has 0.8 m overhead clearance — comfortable for all GMP facility IQ/OQ maintenance access requirements. IBM135-class at 3.41 m cannot be installed in any cleanroom with ceiling below 3.91 m (3.41 m machine + 0.5 m minimum service clearance), eliminating it from every standard Korean pharmaceutical GMP cleanroom without significant structural ceiling modification at 80–200 million KRW per bay plus production downtime.

Q5: What is the EP-ZQ110 machine and mould lead time?

Masin: 60–75 tööpäeva alates tellimuse kinnitamisest ja ettemaksu tegemisest. Vormi valmistamine: 50–60 tööpäeva (H13 SPI B1) või 65–80 tööpäeva (S136 SPI A1 24-õõnsusega PCTG täppistööriistade jaoks). Masin ja vorm toodetakse paralleelselt samaaegseks T1 katsekasutuseks Korea Ever-Poweris enne saatmist.

Q6: What GMP documentation does Korea Ever-Power provide with EP-ZQ110?

Masina andmeleht; FAT-aruanne ostja määratud vaigu ja õõnsuse formaadi kohta; CE-sertifikaat; ISO 9001:2015 sertifikaat; PP-vaigu CoA koos Korea MFDS toidumahutite registreeringuga ja KP plastmahutite standardtestiga KOLAS-akrediteeritud laborist; PCTG Eastman TX1001 FDA 21 CFR 177.2490 toiduga kokkupuutumise kiri + EU 10/2011 vastavusdeklaratsioon. IQ/OQ dokumentatsiooni mall on saadaval nõudmisel.

Q7: What after-sales service does Korea Ever-Power provide in Korea for EP-ZQ110?

Korea Ever-Power Ansan-si, Gyeonggi-do: one week on-site commissioning and operator training; 24/7 remote PLC VPN diagnostic support for 90 days post-commissioning with 2-hour software response SLA; same-day Korean spare parts dispatch; scheduled preventive maintenance on annual service contract. At the EP-ZQ110 production scale (100–400 million bottles per year at 100 ml), unplanned downtime directly impacts batch release schedules — in-country 2-hour remote diagnostic and same-day parts are operationally significant versus North America-based Jomar IBM135 service response times.

Q8: What PCTG optical quality does EP-ZQ110 with S136 SPI A1 tooling achieve at 24-cavity scale?

0.8–1.6% ASTM D1003 integrating sphere haze at 0.5–0.6 mm body wall, verified on Korea Ever-Power ZQ-series T1 trials. This optical quality is maintained at the full 24-cavity tooling scale through uniform barrel temperature control across the 1,100 mm platen width and consistent S136 SPI A1 surface finish across all 24 injection cavities. Jomar IBM135-class standard tooling does not include S136 SPI A1 as a published option and the narrow 559 mm platen limits practical cavity count at PCTG luxury cosmetic dropper vial formats regardless of mould steel choice.

Q9: What is the annual production capacity of EP-ZQ110 at 14 cavities and 100ml format?

At 14 cavities, 3.5 s dry cycle, 5.5 s typical total cycle time at 100 ml pharmaceutical PP, three shifts per day, 330 production days per year: approximately (14 × 3,600 / 5.5) × 24 × 330 = approximately 150–160 million bottles per year at 100 ml format from a single EP-ZQ110 unit. IBM135-class platen constraints at the same 65 mm screw and similar shot weight may limit this to 8–10 cavities at 100 ml due to the 559 mm narrow platen — approximately 85–115 million bottles per year. EP-ZQ110's wider platen enabling 14 versus 8–10 cavities at 100 ml represents a 40–65% annual output advantage per machine investment.

Q10: Which Korea Ever-Power EP-ZQ model replaces Jomar IBM175?

EP-ZQ135 (1,350 kN, screw 70 mm, max shot 650 g, platen 1300 × 500 mm, total power 95 kW, machine 5.5 × 2.0 × 2.4 m, 18 T) replaces Jomar IBM175-class (1,560 kN, screw 70 mm, shot 450/550 g, platen 635 × 1,372 mm, footprint 4.22 × 2.67 × 3.58 m). Dedicated comparison page in the IBM-i masina asendamise juhend.